花旗下调H&H国际(1112.HK)目标价至53.1港元评级“买入”
花旗发表报告表示,预期H&H国际(01112.HK)上半年核心盈利与去年同期6.62亿元人民币(不计2.77亿元人民币汇兑亏损)相比将按年持平,并估计公司上半年收入录低双位数增长,较第一季低单位数增长加速。该行预期由於EBITDA利润率有可能收缩,但被财务开支下降所抵销,料期内核心EBITDA(不计汇兑亏损)将录中单位数温和下跌。

该行指,将H&H国际2019至2021年纯利预测下调7-8%,以反映EBITDA利润率较低及ANC(成人营养产品)业务有效税率较高的因素,维持该股“买入”评级,目标价由56.2港元降至53.1港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.